FDA approval labeling
Executive Summary
On May 9, the full House Energy & Commerce Cmte. passed a bill to lift the current prohibition against stating in Rx drug labeling and advertising that a product has been approved by FDA. The measure, introduced on April 29 by Rep. Waxman (D-Calif.) and passed by his Health Subcmte. May 2, was reported to the House floor without amendment. The situation for DESI drugs not classified as effective was not discussed prior to moving to the floor.
On May 9, the full House Energy & Commerce Cmte. passed a bill
to lift the current prohibition against stating in Rx drug labeling
and advertising that a product has been approved by FDA. The
measure, introduced on April 29 by Rep. Waxman (D-Calif.) and
passed by his Health Subcmte. May 2, was reported to the House
floor without amendment. The situation for DESI drugs not
classified as effective was not discussed prior to moving to the
floor. |